ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

ICICI Prudential Nifty Healthcare ETF

ICICI ICICI Prudential Mutual Fund Jul 2026 — Sep 2026 3 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹231 CrAt NSE closes, Sep 2026
Companies held2020 with an NSE price
Top 10 holdings75.8%Of the equity shown here
Largest holding17.0%Sun Pharmaceutical Industries Limited
12-month turnover—Not enough comparable months

Days to sell half: 0.3 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

3 priced months, Jul 2026 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

75.8% now · highest 77.7%, lowest 75.8%

Companies held

20 now · largest single holding 17.0% of equity

Sector mix

Share of the equity shown · NSE industry

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. Axis NIFTY Healthcare ETFAxis · 20 shared100.0%
  2. DSP Nifty Healthcare Index FundDSP · 20 shared100.0%
  3. DSP Nifty Healthcare ETFDSP · 20 shared100.0%
  4. ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 20 shared99.9%
  5. EODWHFEdelweiss · 18 shared91.8%
  6. Nippon India Nifty Pharma ETFNippon India · 16 shared81.1%
  7. ICICI Prudential Nifty Pharma Index FundICICI Prudential · 16 shared81.1%
  8. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared79.8%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 2 Companies added
Complete exits 2 Companies sold out
Increases 16 More shares than last month
Reductions 2 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Sun Pharmaceutical Industries Limited Healthcare Large Cap 17.00% 39.34 Cr 0.02 Cr by Jul 2026 (3 mo+)
Divi's Laboratories Limited Healthcare Large Cap 10.44% 24.15 Cr 25,993 by Jul 2026 (3 mo+)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 7.43% 17.19 Cr 21,048 by Jul 2026 (3 mo+)
Laurus Labs Limited Healthcare Mid Cap 6.82% 15.77 Cr 79,659 by Jul 2026 (3 mo+)
Cipla Limited Healthcare Large Cap 6.70% 15.49 Cr 0.01 Cr by Jul 2026 (3 mo+)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 6.65% 15.38 Cr 0.01 Cr by Jul 2026 (3 mo+)
Torrent Pharmaceuticals Limited Healthcare Large Cap 6.24% 14.45 Cr 30,098 by Jul 2026 (3 mo+)
Max Healthcare Institute Limited Healthcare Large Cap 6.12% 14.15 Cr 0.02 Cr by Jul 2026 (3 mo+)
Lupin Limited Healthcare Mid Cap 4.36% 10.09 Cr 49,682 by Jul 2026 (3 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 4.09% 9.45 Cr 56,526 by Jul 2026 (3 mo+)
Fortis Healthcare Limited Healthcare Mid Cap 3.55% 8.21 Cr 0.01 Cr by Jul 2026 (3 mo+)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 3.11% 7.19 Cr 30,795 by Jul 2026 (3 mo+)
Alkem Laboratories Limited Healthcare Mid Cap 2.75% 6.37 Cr 12,333 by Jul 2026 (3 mo+)
Zydus Lifesciences Limited Healthcare Mid Cap 2.55% 5.89 Cr 50,684 by Jul 2026 (3 mo+)
Mankind Pharma Limited Healthcare Mid Cap 2.51% 5.80 Cr 23,178 by Jul 2026 (3 mo+)
IPCA Laboratories Limited Healthcare Mid Cap 2.37% 5.48 Cr 28,415 by Jul 2026 (3 mo+)
Biocon Limited Healthcare Mid Cap 2.28% 5.28 Cr 0.01 Cr by Jul 2026 (3 mo+)
Gland Pharma Limited Healthcare Small Cap 2.04% 4.73 Cr 16,300 Sep 2026 (1 mo)
Krishna Institute of Medical Sciences Limited Healthcare Small Cap 1.76% 4.07 Cr 54,583 Sep 2026 (1 mo)
Abbott India Limited Healthcare Mid Cap 1.25% 2.89 Cr 1,065 by Jul 2026 (3 mo+)

Half of its current holdings have been held for 3 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Piramal Pharma Limited Sep 2026 ▼ Complete exit -0.01 Cr
Krishna Institute of Medical Sciences Limited Sep 2026 ▲ New position +54,583
Syngene International Limited Sep 2026 ▼ Complete exit -38,752
Gland Pharma Limited Sep 2026 ▲ New position +16,300
Biocon Limited Sep 2026 ▼ Reducing -2,879
Sun Pharmaceutical Industries Limited Sep 2026 ▲ Increasing +735
Max Healthcare Institute Limited Sep 2026 ▲ Increasing +513
Dr. Reddy's Laboratories Limited Sep 2026 ▲ Increasing +484
Cipla Limited Sep 2026 ▲ Increasing +409
Alkem Laboratories Limited Sep 2026 ▲ Increasing +406
Laurus Labs Limited Sep 2026 ▲ Increasing +354
Fortis Healthcare Limited Sep 2026 ▲ Increasing +352
Zydus Lifesciences Limited Sep 2026 ▼ Reducing -312
Torrent Pharmaceuticals Limited Sep 2026 ▲ Increasing +199
Lupin Limited Sep 2026 ▲ Increasing +182
Aurobindo Pharma Limited Sep 2026 ▲ Increasing +106
Glenmark Pharmaceuticals Limited Sep 2026 ▲ Increasing +105
Mankind Pharma Limited Sep 2026 ▲ Increasing +102
IPCA Laboratories Limited Sep 2026 ▲ Increasing +102
Divi's Laboratories Limited Sep 2026 ▲ Increasing +89
Apollo Hospitals Enterprise Limited Sep 2026 ▲ Increasing +72
Abbott India Limited Sep 2026 ▲ Increasing +3
Sun Pharmaceutical Industries Limited Aug 2026 ▼ Reducing -418
Max Healthcare Institute Limited Aug 2026 ▼ Reducing -291
Biocon Limited Aug 2026 ▼ Reducing -279
Piramal Pharma Limited Aug 2026 ▼ Reducing -244
Dr. Reddy's Laboratories Limited Aug 2026 ▼ Reducing -239
Cipla Limited Aug 2026 ▼ Reducing -219
Fortis Healthcare Limited Aug 2026 ▼ Reducing -204
Laurus Labs Limited Aug 2026 ▼ Reducing -153
Aurobindo Pharma Limited Aug 2026 ▼ Reducing -107
Lupin Limited Aug 2026 ▼ Reducing -98
Zydus Lifesciences Limited Aug 2026 ▼ Reducing -95
Syngene International Limited Aug 2026 ▼ Reducing -72
Glenmark Pharmaceuticals Limited Aug 2026 ▼ Reducing -61
Torrent Pharmaceuticals Limited Aug 2026 ▼ Reducing -59
IPCA Laboratories Limited Aug 2026 ▼ Reducing -52
Divi's Laboratories Limited Aug 2026 ▼ Reducing -51
Mankind Pharma Limited Aug 2026 ▼ Reducing -46
Apollo Hospitals Enterprise Limited Aug 2026 ▼ Reducing -42
Alkem Laboratories Limited Aug 2026 ▼ Reducing -24
Abbott India Limited Aug 2026 ▼ Reducing -2

Changes compare consecutive month-end disclosures for this portfolio only.